nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Epirubicin—liver cancer	0.392	0.653	CbGbCtD
Zoledronate—ABCC1—Doxorubicin—liver cancer	0.208	0.347	CbGbCtD
Zoledronate—Oesophagitis—Epirubicin—liver cancer	0.000927	0.00278	CcSEcCtD
Zoledronate—Hyperkalaemia—Doxorubicin—liver cancer	0.000922	0.00276	CcSEcCtD
Zoledronate—Neoplasm—Epirubicin—liver cancer	0.000917	0.00275	CcSEcCtD
Zoledronate—Influenza like illness—Doxorubicin—liver cancer	0.000911	0.00273	CcSEcCtD
Zoledronate—Candida infection—Doxorubicin—liver cancer	0.000896	0.00269	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000892	0.00267	CcSEcCtD
Zoledronate—Blood urea increased—Doxorubicin—liver cancer	0.000886	0.00266	CcSEcCtD
Zoledronate—Dyspnoea—Sorafenib—liver cancer	0.000873	0.00262	CcSEcCtD
Zoledronate—Dyspepsia—Sorafenib—liver cancer	0.000862	0.00258	CcSEcCtD
Zoledronate—Oesophagitis—Doxorubicin—liver cancer	0.000858	0.00257	CcSEcCtD
Zoledronate—Decreased appetite—Sorafenib—liver cancer	0.000851	0.00255	CcSEcCtD
Zoledronate—Neoplasm—Doxorubicin—liver cancer	0.000849	0.00254	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Sorafenib—liver cancer	0.000845	0.00253	CcSEcCtD
Zoledronate—Fatigue—Sorafenib—liver cancer	0.000844	0.00253	CcSEcCtD
Zoledronate—Constipation—Sorafenib—liver cancer	0.000837	0.00251	CcSEcCtD
Zoledronate—Pain—Sorafenib—liver cancer	0.000837	0.00251	CcSEcCtD
Zoledronate—Eye pain—Epirubicin—liver cancer	0.000816	0.00245	CcSEcCtD
Zoledronate—Gastrointestinal pain—Sorafenib—liver cancer	0.000801	0.0024	CcSEcCtD
Zoledronate—Renal failure acute—Epirubicin—liver cancer	0.000798	0.00239	CcSEcCtD
Zoledronate—Urticaria—Sorafenib—liver cancer	0.000778	0.00233	CcSEcCtD
Zoledronate—Body temperature increased—Sorafenib—liver cancer	0.000774	0.00232	CcSEcCtD
Zoledronate—Abdominal pain—Sorafenib—liver cancer	0.000774	0.00232	CcSEcCtD
Zoledronate—Renal impairment—Epirubicin—liver cancer	0.000774	0.00232	CcSEcCtD
Zoledronate—Eye pain—Doxorubicin—liver cancer	0.000755	0.00226	CcSEcCtD
Zoledronate—Lethargy—Epirubicin—liver cancer	0.000751	0.00225	CcSEcCtD
Zoledronate—Renal failure acute—Doxorubicin—liver cancer	0.000738	0.00221	CcSEcCtD
Zoledronate—Pain in extremity—Epirubicin—liver cancer	0.000736	0.00221	CcSEcCtD
Zoledronate—Osteoarthritis—Epirubicin—liver cancer	0.000736	0.00221	CcSEcCtD
Zoledronate—Hypersensitivity—Sorafenib—liver cancer	0.000721	0.00216	CcSEcCtD
Zoledronate—Renal impairment—Doxorubicin—liver cancer	0.000716	0.00215	CcSEcCtD
Zoledronate—Asthenia—Sorafenib—liver cancer	0.000703	0.00211	CcSEcCtD
Zoledronate—Lethargy—Doxorubicin—liver cancer	0.000695	0.00208	CcSEcCtD
Zoledronate—Pruritus—Sorafenib—liver cancer	0.000693	0.00208	CcSEcCtD
Zoledronate—Blood creatinine increased—Epirubicin—liver cancer	0.00069	0.00207	CcSEcCtD
Zoledronate—Dehydration—Epirubicin—liver cancer	0.000685	0.00205	CcSEcCtD
Zoledronate—Pain in extremity—Doxorubicin—liver cancer	0.000681	0.00204	CcSEcCtD
Zoledronate—Osteoarthritis—Doxorubicin—liver cancer	0.000681	0.00204	CcSEcCtD
Zoledronate—Abdominal pain upper—Epirubicin—liver cancer	0.000672	0.00202	CcSEcCtD
Zoledronate—Hypokalaemia—Epirubicin—liver cancer	0.00067	0.00201	CcSEcCtD
Zoledronate—Diarrhoea—Sorafenib—liver cancer	0.00067	0.00201	CcSEcCtD
Zoledronate—Nasopharyngitis—Epirubicin—liver cancer	0.000658	0.00197	CcSEcCtD
Zoledronate—Gastritis—Epirubicin—liver cancer	0.000652	0.00195	CcSEcCtD
Zoledronate—Muscular weakness—Epirubicin—liver cancer	0.000649	0.00195	CcSEcCtD
Zoledronate—Dizziness—Sorafenib—liver cancer	0.000648	0.00194	CcSEcCtD
Zoledronate—Abdominal distension—Epirubicin—liver cancer	0.000641	0.00192	CcSEcCtD
Zoledronate—Blood creatinine increased—Doxorubicin—liver cancer	0.000638	0.00191	CcSEcCtD
Zoledronate—Influenza—Epirubicin—liver cancer	0.000636	0.00191	CcSEcCtD
Zoledronate—Asthma—Epirubicin—liver cancer	0.000636	0.00191	CcSEcCtD
Zoledronate—Dysphagia—Epirubicin—liver cancer	0.000636	0.00191	CcSEcCtD
Zoledronate—Dehydration—Doxorubicin—liver cancer	0.000634	0.0019	CcSEcCtD
Zoledronate—Vomiting—Sorafenib—liver cancer	0.000623	0.00187	CcSEcCtD
Zoledronate—Abdominal pain upper—Doxorubicin—liver cancer	0.000622	0.00187	CcSEcCtD
Zoledronate—Hypokalaemia—Doxorubicin—liver cancer	0.00062	0.00186	CcSEcCtD
Zoledronate—Rash—Sorafenib—liver cancer	0.000617	0.00185	CcSEcCtD
Zoledronate—Dermatitis—Sorafenib—liver cancer	0.000617	0.00185	CcSEcCtD
Zoledronate—Headache—Sorafenib—liver cancer	0.000613	0.00184	CcSEcCtD
Zoledronate—Nasopharyngitis—Doxorubicin—liver cancer	0.000609	0.00183	CcSEcCtD
Zoledronate—Pancytopenia—Epirubicin—liver cancer	0.000604	0.00181	CcSEcCtD
Zoledronate—Gastritis—Doxorubicin—liver cancer	0.000603	0.00181	CcSEcCtD
Zoledronate—Muscular weakness—Doxorubicin—liver cancer	0.000601	0.0018	CcSEcCtD
Zoledronate—Neutropenia—Epirubicin—liver cancer	0.000595	0.00178	CcSEcCtD
Zoledronate—Abdominal distension—Doxorubicin—liver cancer	0.000593	0.00178	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Epirubicin—liver cancer	0.000591	0.00177	CcSEcCtD
Zoledronate—Influenza—Doxorubicin—liver cancer	0.000589	0.00177	CcSEcCtD
Zoledronate—Dysphagia—Doxorubicin—liver cancer	0.000589	0.00177	CcSEcCtD
Zoledronate—Asthma—Doxorubicin—liver cancer	0.000589	0.00177	CcSEcCtD
Zoledronate—Pollakiuria—Epirubicin—liver cancer	0.000588	0.00176	CcSEcCtD
Zoledronate—Nausea—Sorafenib—liver cancer	0.000582	0.00174	CcSEcCtD
Zoledronate—Weight increased—Epirubicin—liver cancer	0.000579	0.00174	CcSEcCtD
Zoledronate—Weight decreased—Epirubicin—liver cancer	0.000576	0.00173	CcSEcCtD
Zoledronate—Infestation NOS—Epirubicin—liver cancer	0.000567	0.0017	CcSEcCtD
Zoledronate—Infestation—Epirubicin—liver cancer	0.000567	0.0017	CcSEcCtD
Zoledronate—Pancytopenia—Doxorubicin—liver cancer	0.000559	0.00168	CcSEcCtD
Zoledronate—Renal failure—Epirubicin—liver cancer	0.000558	0.00167	CcSEcCtD
Zoledronate—Stomatitis—Epirubicin—liver cancer	0.000553	0.00166	CcSEcCtD
Zoledronate—Conjunctivitis—Epirubicin—liver cancer	0.000552	0.00165	CcSEcCtD
Zoledronate—Urinary tract infection—Epirubicin—liver cancer	0.000552	0.00165	CcSEcCtD
Zoledronate—Neutropenia—Doxorubicin—liver cancer	0.000551	0.00165	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000547	0.00164	CcSEcCtD
Zoledronate—Pollakiuria—Doxorubicin—liver cancer	0.000544	0.00163	CcSEcCtD
Zoledronate—Haematuria—Epirubicin—liver cancer	0.000541	0.00162	CcSEcCtD
Zoledronate—Weight increased—Doxorubicin—liver cancer	0.000536	0.00161	CcSEcCtD
Zoledronate—Weight decreased—Doxorubicin—liver cancer	0.000533	0.0016	CcSEcCtD
Zoledronate—Agranulocytosis—Epirubicin—liver cancer	0.00053	0.00159	CcSEcCtD
Zoledronate—Infestation NOS—Doxorubicin—liver cancer	0.000525	0.00157	CcSEcCtD
Zoledronate—Infestation—Doxorubicin—liver cancer	0.000525	0.00157	CcSEcCtD
Zoledronate—Bradycardia—Epirubicin—liver cancer	0.000519	0.00155	CcSEcCtD
Zoledronate—Renal failure—Doxorubicin—liver cancer	0.000516	0.00155	CcSEcCtD
Zoledronate—Stomatitis—Doxorubicin—liver cancer	0.000512	0.00153	CcSEcCtD
Zoledronate—Conjunctivitis—Doxorubicin—liver cancer	0.00051	0.00153	CcSEcCtD
Zoledronate—Urinary tract infection—Doxorubicin—liver cancer	0.00051	0.00153	CcSEcCtD
Zoledronate—Hypoaesthesia—Epirubicin—liver cancer	0.000507	0.00152	CcSEcCtD
Zoledronate—Urinary tract disorder—Epirubicin—liver cancer	0.000503	0.00151	CcSEcCtD
Zoledronate—Oedema peripheral—Epirubicin—liver cancer	0.000502	0.0015	CcSEcCtD
Zoledronate—Haematuria—Doxorubicin—liver cancer	0.000501	0.0015	CcSEcCtD
Zoledronate—Connective tissue disorder—Epirubicin—liver cancer	0.000501	0.0015	CcSEcCtD
Zoledronate—Urethral disorder—Epirubicin—liver cancer	0.000499	0.0015	CcSEcCtD
Zoledronate—Agranulocytosis—Doxorubicin—liver cancer	0.00049	0.00147	CcSEcCtD
Zoledronate—Bradycardia—Doxorubicin—liver cancer	0.00048	0.00144	CcSEcCtD
Zoledronate—Eye disorder—Epirubicin—liver cancer	0.000476	0.00143	CcSEcCtD
Zoledronate—Flushing—Epirubicin—liver cancer	0.000473	0.00142	CcSEcCtD
Zoledronate—Cardiac disorder—Epirubicin—liver cancer	0.000473	0.00142	CcSEcCtD
Zoledronate—Hypoaesthesia—Doxorubicin—liver cancer	0.000469	0.00141	CcSEcCtD
Zoledronate—Urinary tract disorder—Doxorubicin—liver cancer	0.000465	0.0014	CcSEcCtD
Zoledronate—Oedema peripheral—Doxorubicin—liver cancer	0.000464	0.00139	CcSEcCtD
Zoledronate—Connective tissue disorder—Doxorubicin—liver cancer	0.000463	0.00139	CcSEcCtD
Zoledronate—Angiopathy—Epirubicin—liver cancer	0.000462	0.00139	CcSEcCtD
Zoledronate—Urethral disorder—Doxorubicin—liver cancer	0.000462	0.00139	CcSEcCtD
Zoledronate—Immune system disorder—Epirubicin—liver cancer	0.00046	0.00138	CcSEcCtD
Zoledronate—Mediastinal disorder—Epirubicin—liver cancer	0.000459	0.00138	CcSEcCtD
Zoledronate—Chills—Epirubicin—liver cancer	0.000457	0.00137	CcSEcCtD
Zoledronate—Arrhythmia—Epirubicin—liver cancer	0.000455	0.00136	CcSEcCtD
Zoledronate—Alopecia—Epirubicin—liver cancer	0.00045	0.00135	CcSEcCtD
Zoledronate—Mental disorder—Epirubicin—liver cancer	0.000446	0.00134	CcSEcCtD
Zoledronate—Erythema—Epirubicin—liver cancer	0.000443	0.00133	CcSEcCtD
Zoledronate—Malnutrition—Epirubicin—liver cancer	0.000443	0.00133	CcSEcCtD
Zoledronate—Eye disorder—Doxorubicin—liver cancer	0.00044	0.00132	CcSEcCtD
Zoledronate—Cardiac disorder—Doxorubicin—liver cancer	0.000437	0.00131	CcSEcCtD
Zoledronate—Flushing—Doxorubicin—liver cancer	0.000437	0.00131	CcSEcCtD
Zoledronate—Dysgeusia—Epirubicin—liver cancer	0.000434	0.0013	CcSEcCtD
Zoledronate—Back pain—Epirubicin—liver cancer	0.000429	0.00129	CcSEcCtD
Zoledronate—Angiopathy—Doxorubicin—liver cancer	0.000428	0.00128	CcSEcCtD
Zoledronate—Muscle spasms—Epirubicin—liver cancer	0.000426	0.00128	CcSEcCtD
Zoledronate—Immune system disorder—Doxorubicin—liver cancer	0.000426	0.00128	CcSEcCtD
Zoledronate—Mediastinal disorder—Doxorubicin—liver cancer	0.000425	0.00127	CcSEcCtD
Zoledronate—Chills—Doxorubicin—liver cancer	0.000423	0.00127	CcSEcCtD
Zoledronate—Arrhythmia—Doxorubicin—liver cancer	0.000421	0.00126	CcSEcCtD
Zoledronate—Vision blurred—Epirubicin—liver cancer	0.000418	0.00125	CcSEcCtD
Zoledronate—Alopecia—Doxorubicin—liver cancer	0.000416	0.00125	CcSEcCtD
Zoledronate—Mental disorder—Doxorubicin—liver cancer	0.000413	0.00124	CcSEcCtD
Zoledronate—Ill-defined disorder—Epirubicin—liver cancer	0.000411	0.00123	CcSEcCtD
Zoledronate—Erythema—Doxorubicin—liver cancer	0.00041	0.00123	CcSEcCtD
Zoledronate—Malnutrition—Doxorubicin—liver cancer	0.00041	0.00123	CcSEcCtD
Zoledronate—Anaemia—Epirubicin—liver cancer	0.00041	0.00123	CcSEcCtD
Zoledronate—Agitation—Epirubicin—liver cancer	0.000407	0.00122	CcSEcCtD
Zoledronate—Dysgeusia—Doxorubicin—liver cancer	0.000402	0.0012	CcSEcCtD
Zoledronate—Malaise—Epirubicin—liver cancer	0.0004	0.0012	CcSEcCtD
Zoledronate—Vertigo—Epirubicin—liver cancer	0.000398	0.00119	CcSEcCtD
Zoledronate—Syncope—Epirubicin—liver cancer	0.000398	0.00119	CcSEcCtD
Zoledronate—Leukopenia—Epirubicin—liver cancer	0.000397	0.00119	CcSEcCtD
Zoledronate—Back pain—Doxorubicin—liver cancer	0.000397	0.00119	CcSEcCtD
Zoledronate—Muscle spasms—Doxorubicin—liver cancer	0.000394	0.00118	CcSEcCtD
Zoledronate—Palpitations—Epirubicin—liver cancer	0.000392	0.00117	CcSEcCtD
Zoledronate—Loss of consciousness—Epirubicin—liver cancer	0.00039	0.00117	CcSEcCtD
Zoledronate—Cough—Epirubicin—liver cancer	0.000387	0.00116	CcSEcCtD
Zoledronate—Vision blurred—Doxorubicin—liver cancer	0.000387	0.00116	CcSEcCtD
Zoledronate—Convulsion—Epirubicin—liver cancer	0.000384	0.00115	CcSEcCtD
Zoledronate—Hypertension—Epirubicin—liver cancer	0.000383	0.00115	CcSEcCtD
Zoledronate—Ill-defined disorder—Doxorubicin—liver cancer	0.000381	0.00114	CcSEcCtD
Zoledronate—Anaemia—Doxorubicin—liver cancer	0.000379	0.00114	CcSEcCtD
Zoledronate—Myalgia—Epirubicin—liver cancer	0.000377	0.00113	CcSEcCtD
Zoledronate—Chest pain—Epirubicin—liver cancer	0.000377	0.00113	CcSEcCtD
Zoledronate—Arthralgia—Epirubicin—liver cancer	0.000377	0.00113	CcSEcCtD
Zoledronate—Agitation—Doxorubicin—liver cancer	0.000377	0.00113	CcSEcCtD
Zoledronate—Anxiety—Epirubicin—liver cancer	0.000376	0.00113	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000375	0.00112	CcSEcCtD
Zoledronate—Discomfort—Epirubicin—liver cancer	0.000373	0.00112	CcSEcCtD
Zoledronate—Malaise—Doxorubicin—liver cancer	0.00037	0.00111	CcSEcCtD
Zoledronate—Dry mouth—Epirubicin—liver cancer	0.000369	0.00111	CcSEcCtD
Zoledronate—Vertigo—Doxorubicin—liver cancer	0.000369	0.00111	CcSEcCtD
Zoledronate—Syncope—Doxorubicin—liver cancer	0.000368	0.0011	CcSEcCtD
Zoledronate—Leukopenia—Doxorubicin—liver cancer	0.000367	0.0011	CcSEcCtD
Zoledronate—Confusional state—Epirubicin—liver cancer	0.000365	0.00109	CcSEcCtD
Zoledronate—Palpitations—Doxorubicin—liver cancer	0.000363	0.00109	CcSEcCtD
Zoledronate—Oedema—Epirubicin—liver cancer	0.000362	0.00108	CcSEcCtD
Zoledronate—Anaphylactic shock—Epirubicin—liver cancer	0.000362	0.00108	CcSEcCtD
Zoledronate—Loss of consciousness—Doxorubicin—liver cancer	0.000361	0.00108	CcSEcCtD
Zoledronate—Infection—Epirubicin—liver cancer	0.00036	0.00108	CcSEcCtD
Zoledronate—Cough—Doxorubicin—liver cancer	0.000358	0.00107	CcSEcCtD
Zoledronate—Shock—Epirubicin—liver cancer	0.000356	0.00107	CcSEcCtD
Zoledronate—Convulsion—Doxorubicin—liver cancer	0.000355	0.00107	CcSEcCtD
Zoledronate—Nervous system disorder—Epirubicin—liver cancer	0.000355	0.00106	CcSEcCtD
Zoledronate—Thrombocytopenia—Epirubicin—liver cancer	0.000354	0.00106	CcSEcCtD
Zoledronate—Hypertension—Doxorubicin—liver cancer	0.000354	0.00106	CcSEcCtD
Zoledronate—Tachycardia—Epirubicin—liver cancer	0.000353	0.00106	CcSEcCtD
Zoledronate—Skin disorder—Epirubicin—liver cancer	0.000352	0.00105	CcSEcCtD
Zoledronate—Hyperhidrosis—Epirubicin—liver cancer	0.00035	0.00105	CcSEcCtD
Zoledronate—Myalgia—Doxorubicin—liver cancer	0.000349	0.00105	CcSEcCtD
Zoledronate—Chest pain—Doxorubicin—liver cancer	0.000349	0.00105	CcSEcCtD
Zoledronate—Arthralgia—Doxorubicin—liver cancer	0.000349	0.00105	CcSEcCtD
Zoledronate—Anxiety—Doxorubicin—liver cancer	0.000348	0.00104	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000347	0.00104	CcSEcCtD
Zoledronate—Discomfort—Doxorubicin—liver cancer	0.000345	0.00103	CcSEcCtD
Zoledronate—Anorexia—Epirubicin—liver cancer	0.000345	0.00103	CcSEcCtD
Zoledronate—Dry mouth—Doxorubicin—liver cancer	0.000342	0.00102	CcSEcCtD
Zoledronate—Hypotension—Epirubicin—liver cancer	0.000338	0.00101	CcSEcCtD
Zoledronate—Confusional state—Doxorubicin—liver cancer	0.000338	0.00101	CcSEcCtD
Zoledronate—Oedema—Doxorubicin—liver cancer	0.000335	0.001	CcSEcCtD
Zoledronate—Anaphylactic shock—Doxorubicin—liver cancer	0.000335	0.001	CcSEcCtD
Zoledronate—Infection—Doxorubicin—liver cancer	0.000333	0.000997	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00033	0.000989	CcSEcCtD
Zoledronate—Shock—Doxorubicin—liver cancer	0.000329	0.000988	CcSEcCtD
Zoledronate—Nervous system disorder—Doxorubicin—liver cancer	0.000328	0.000985	CcSEcCtD
Zoledronate—Thrombocytopenia—Doxorubicin—liver cancer	0.000328	0.000983	CcSEcCtD
Zoledronate—Insomnia—Epirubicin—liver cancer	0.000327	0.000981	CcSEcCtD
Zoledronate—Tachycardia—Doxorubicin—liver cancer	0.000327	0.00098	CcSEcCtD
Zoledronate—Skin disorder—Doxorubicin—liver cancer	0.000325	0.000975	CcSEcCtD
Zoledronate—Paraesthesia—Epirubicin—liver cancer	0.000325	0.000974	CcSEcCtD
Zoledronate—Hyperhidrosis—Doxorubicin—liver cancer	0.000324	0.000971	CcSEcCtD
Zoledronate—Dyspnoea—Epirubicin—liver cancer	0.000323	0.000967	CcSEcCtD
Zoledronate—Somnolence—Epirubicin—liver cancer	0.000322	0.000965	CcSEcCtD
Zoledronate—Anorexia—Doxorubicin—liver cancer	0.000319	0.000957	CcSEcCtD
Zoledronate—Dyspepsia—Epirubicin—liver cancer	0.000319	0.000955	CcSEcCtD
Zoledronate—Decreased appetite—Epirubicin—liver cancer	0.000315	0.000943	CcSEcCtD
Zoledronate—Hypotension—Doxorubicin—liver cancer	0.000313	0.000938	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Epirubicin—liver cancer	0.000312	0.000937	CcSEcCtD
Zoledronate—Fatigue—Epirubicin—liver cancer	0.000312	0.000935	CcSEcCtD
Zoledronate—Constipation—Epirubicin—liver cancer	0.000309	0.000928	CcSEcCtD
Zoledronate—Pain—Epirubicin—liver cancer	0.000309	0.000928	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000305	0.000915	CcSEcCtD
Zoledronate—Insomnia—Doxorubicin—liver cancer	0.000303	0.000908	CcSEcCtD
Zoledronate—Paraesthesia—Doxorubicin—liver cancer	0.000301	0.000901	CcSEcCtD
Zoledronate—Dyspnoea—Doxorubicin—liver cancer	0.000299	0.000895	CcSEcCtD
Zoledronate—Feeling abnormal—Epirubicin—liver cancer	0.000298	0.000894	CcSEcCtD
Zoledronate—FDPS—SREBP signalling—AKT1—liver cancer	0.000298	0.00447	CbGpPWpGaD
Zoledronate—Somnolence—Doxorubicin—liver cancer	0.000298	0.000892	CcSEcCtD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000297	0.00446	CbGpPWpGaD
Zoledronate—Gastrointestinal pain—Epirubicin—liver cancer	0.000296	0.000887	CcSEcCtD
Zoledronate—Dyspepsia—Doxorubicin—liver cancer	0.000295	0.000884	CcSEcCtD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000293	0.00441	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PSMA4—liver cancer	0.000293	0.00439	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PSMD10—liver cancer	0.000293	0.00439	CbGpPWpGaD
Zoledronate—Decreased appetite—Doxorubicin—liver cancer	0.000291	0.000873	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000289	0.000867	CcSEcCtD
Zoledronate—Fatigue—Doxorubicin—liver cancer	0.000289	0.000866	CcSEcCtD
Zoledronate—Urticaria—Epirubicin—liver cancer	0.000287	0.000862	CcSEcCtD
Zoledronate—Constipation—Doxorubicin—liver cancer	0.000286	0.000858	CcSEcCtD
Zoledronate—Pain—Doxorubicin—liver cancer	0.000286	0.000858	CcSEcCtD
Zoledronate—Abdominal pain—Epirubicin—liver cancer	0.000286	0.000858	CcSEcCtD
Zoledronate—Body temperature increased—Epirubicin—liver cancer	0.000286	0.000858	CcSEcCtD
Zoledronate—GGPS1—Metabolism—GOT2—liver cancer	0.000285	0.00427	CbGpPWpGaD
Zoledronate—Feeling abnormal—Doxorubicin—liver cancer	0.000276	0.000827	CcSEcCtD
Zoledronate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—liver cancer	0.000275	0.00413	CbGpPWpGaD
Zoledronate—Gastrointestinal pain—Doxorubicin—liver cancer	0.000274	0.000821	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00027	0.00406	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CYP2E1—liver cancer	0.000268	0.00402	CbGpPWpGaD
Zoledronate—Hypersensitivity—Epirubicin—liver cancer	0.000267	0.000799	CcSEcCtD
Zoledronate—Urticaria—Doxorubicin—liver cancer	0.000266	0.000798	CcSEcCtD
Zoledronate—Body temperature increased—Doxorubicin—liver cancer	0.000265	0.000794	CcSEcCtD
Zoledronate—Abdominal pain—Doxorubicin—liver cancer	0.000265	0.000794	CcSEcCtD
Zoledronate—CA2—Metabolism—UGDH—liver cancer	0.000265	0.00397	CbGpPWpGaD
Zoledronate—Asthenia—Epirubicin—liver cancer	0.00026	0.000778	CcSEcCtD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000259	0.00389	CbGpPWpGaD
Zoledronate—Pruritus—Epirubicin—liver cancer	0.000256	0.000768	CcSEcCtD
Zoledronate—GGPS1—Metabolism—CYCS—liver cancer	0.00025	0.00376	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GLUL—liver cancer	0.000249	0.00373	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CPT1B—liver cancer	0.000249	0.00373	CbGpPWpGaD
Zoledronate—CA2—Metabolism—EPT1—liver cancer	0.000249	0.00373	CbGpPWpGaD
Zoledronate—Diarrhoea—Epirubicin—liver cancer	0.000248	0.000742	CcSEcCtD
Zoledronate—Hypersensitivity—Doxorubicin—liver cancer	0.000247	0.00074	CcSEcCtD
Zoledronate—GGPS1—Metabolism—GGT1—liver cancer	0.000246	0.00369	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—GOT1—liver cancer	0.000246	0.00369	CbGpPWpGaD
Zoledronate—Asthenia—Doxorubicin—liver cancer	0.00024	0.00072	CcSEcCtD
Zoledronate—CA14—Metabolism—NR1H4—liver cancer	0.00024	0.0036	CbGpPWpGaD
Zoledronate—Dizziness—Epirubicin—liver cancer	0.000239	0.000717	CcSEcCtD
Zoledronate—ABCC1—Disease—APCS—liver cancer	0.000237	0.00356	CbGpPWpGaD
Zoledronate—Pruritus—Doxorubicin—liver cancer	0.000237	0.00071	CcSEcCtD
Zoledronate—CA14—Metabolism—GSTA3—liver cancer	0.000236	0.00354	CbGpPWpGaD
Zoledronate—CA2—Metabolism—TAT—liver cancer	0.000236	0.00354	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000235	0.00354	CbGpPWpGaD
Zoledronate—Vomiting—Epirubicin—liver cancer	0.00023	0.00069	CcSEcCtD
Zoledronate—Diarrhoea—Doxorubicin—liver cancer	0.000229	0.000687	CcSEcCtD
Zoledronate—Rash—Epirubicin—liver cancer	0.000228	0.000684	CcSEcCtD
Zoledronate—Dermatitis—Epirubicin—liver cancer	0.000228	0.000683	CcSEcCtD
Zoledronate—Headache—Epirubicin—liver cancer	0.000227	0.00068	CcSEcCtD
Zoledronate—Dizziness—Doxorubicin—liver cancer	0.000221	0.000664	CcSEcCtD
Zoledronate—GGPS1—Metabolism—GSTP1—liver cancer	0.000221	0.00331	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—HMOX1—liver cancer	0.000218	0.00327	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GLUL—liver cancer	0.000217	0.00326	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CPT1B—liver cancer	0.000217	0.00326	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GSTA4—liver cancer	0.000216	0.00324	CbGpPWpGaD
Zoledronate—Nausea—Epirubicin—liver cancer	0.000215	0.000644	CcSEcCtD
Zoledronate—Vomiting—Doxorubicin—liver cancer	0.000213	0.000638	CcSEcCtD
Zoledronate—Rash—Doxorubicin—liver cancer	0.000211	0.000633	CcSEcCtD
Zoledronate—Dermatitis—Doxorubicin—liver cancer	0.000211	0.000632	CcSEcCtD
Zoledronate—CA14—Metabolism—GSTA2—liver cancer	0.00021	0.00316	CbGpPWpGaD
Zoledronate—Headache—Doxorubicin—liver cancer	0.00021	0.000629	CcSEcCtD
Zoledronate—FDPS—Metabolism—NR1H4—liver cancer	0.00021	0.00315	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CPT1B—liver cancer	0.00021	0.00315	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GLUL—liver cancer	0.00021	0.00315	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTA3—liver cancer	0.000206	0.00309	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GSTA1—liver cancer	0.000203	0.00304	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—GSTM1—liver cancer	0.000203	0.00304	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NR1H4—liver cancer	0.000202	0.00304	CbGpPWpGaD
Zoledronate—CA14—Metabolism—NAT2—liver cancer	0.0002	0.00301	CbGpPWpGaD
Zoledronate—Nausea—Doxorubicin—liver cancer	0.000199	0.000596	CcSEcCtD
Zoledronate—CA12—Metabolism—GSTA3—liver cancer	0.000199	0.00298	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ALDOB—liver cancer	0.000192	0.00289	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CYP1A1—liver cancer	0.000192	0.00289	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTA4—liver cancer	0.000188	0.00283	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000185	0.00277	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000184	0.00277	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTA2—liver cancer	0.000184	0.00276	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CRABP1—liver cancer	0.000183	0.00275	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTA4—liver cancer	0.000182	0.00273	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—MTHFR—liver cancer	0.000179	0.00269	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTA1—liver cancer	0.000177	0.00266	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTA2—liver cancer	0.000177	0.00266	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000176	0.00265	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PPARA—liver cancer	0.000176	0.00264	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—NAT2—liver cancer	0.000175	0.00263	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000174	0.00262	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTA1—liver cancer	0.000171	0.00257	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NAT2—liver cancer	0.000169	0.00254	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000169	0.00254	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000169	0.00254	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000168	0.00253	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ALDOB—liver cancer	0.000168	0.00252	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000168	0.00252	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ALDOB—liver cancer	0.000162	0.00243	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CPT1B—liver cancer	0.00016	0.00241	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GLUL—liver cancer	0.00016	0.00241	CbGpPWpGaD
Zoledronate—CA14—Metabolism—HPGDS—liver cancer	0.00016	0.00241	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CRABP1—liver cancer	0.00016	0.00241	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00016	0.0024	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000158	0.00237	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NR1H4—liver cancer	0.000155	0.00232	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CRABP1—liver cancer	0.000155	0.00232	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTA3—liver cancer	0.000152	0.00228	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CG—liver cancer	0.000151	0.00226	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PPARG—liver cancer	0.000145	0.00218	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000144	0.00217	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PSMD10—liver cancer	0.000143	0.00215	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PSMA4—liver cancer	0.000143	0.00215	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—HPGDS—liver cancer	0.00014	0.0021	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000139	0.00209	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTA4—liver cancer	0.000139	0.00209	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GOT2—liver cancer	0.000139	0.00209	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTA2—liver cancer	0.000135	0.00203	CbGpPWpGaD
Zoledronate—CA12—Metabolism—HPGDS—liver cancer	0.000135	0.00203	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CD—liver cancer	0.000132	0.00199	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTA1—liver cancer	0.000131	0.00196	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CYP2E1—liver cancer	0.000131	0.00196	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ALB—liver cancer	0.000131	0.00196	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NAT2—liver cancer	0.000129	0.00194	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000128	0.00193	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—UGDH—liver cancer	0.000128	0.00192	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000127	0.0019	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000125	0.00188	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PSMA4—liver cancer	0.000125	0.00187	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PSMD10—liver cancer	0.000125	0.00187	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALDOB—liver cancer	0.000124	0.00186	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CYCS—liver cancer	0.000122	0.00184	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GOT2—liver cancer	0.000121	0.00182	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PSMD10—liver cancer	0.00012	0.00181	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PSMA4—liver cancer	0.00012	0.00181	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—EPT1—liver cancer	0.00012	0.00181	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GGT1—liver cancer	0.00012	0.0018	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GOT1—liver cancer	0.00012	0.0018	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CRABP1—liver cancer	0.000118	0.00177	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GOT2—liver cancer	0.000117	0.00176	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CB—liver cancer	0.000115	0.00173	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP2E1—liver cancer	0.000114	0.00171	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TAT—liver cancer	0.000114	0.00171	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000112	0.00169	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000111	0.00166	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP2E1—liver cancer	0.00011	0.00165	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GSTP1—liver cancer	0.000108	0.00162	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYCS—liver cancer	0.000107	0.0016	CbGpPWpGaD
Zoledronate—CA14—Metabolism—HMOX1—liver cancer	0.000106	0.0016	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GGT1—liver cancer	0.000105	0.00157	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GOT1—liver cancer	0.000105	0.00157	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HPGDS—liver cancer	0.000103	0.00155	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYCS—liver cancer	0.000103	0.00155	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GGT1—liver cancer	0.000101	0.00152	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GOT1—liver cancer	0.000101	0.00152	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GSTM1—liver cancer	9.9e-05	0.00149	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTP1—liver cancer	9.42e-05	0.00141	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CYP1A1—liver cancer	9.39e-05	0.00141	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—HMOX1—liver cancer	9.29e-05	0.00139	CbGpPWpGaD
Zoledronate—ABCC1—Disease—LTF—liver cancer	9.26e-05	0.00139	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PSMA4—liver cancer	9.21e-05	0.00138	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PSMD10—liver cancer	9.21e-05	0.00138	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTP1—liver cancer	9.08e-05	0.00136	CbGpPWpGaD
Zoledronate—CA12—Metabolism—HMOX1—liver cancer	8.96e-05	0.00134	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GOT2—liver cancer	8.95e-05	0.00134	CbGpPWpGaD
Zoledronate—CA14—Metabolism—MTHFR—liver cancer	8.75e-05	0.00131	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTM1—liver cancer	8.65e-05	0.0013	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PPARA—liver cancer	8.59e-05	0.00129	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP2E1—liver cancer	8.42e-05	0.00126	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	8.4e-05	0.00126	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTM1—liver cancer	8.35e-05	0.00125	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP1A1—liver cancer	8.2e-05	0.00123	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—CYCS—liver cancer	8.14e-05	0.00122	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP1A1—liver cancer	7.91e-05	0.00119	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYCS—liver cancer	7.88e-05	0.00118	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GLUL—liver cancer	7.76e-05	0.00117	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CPT1B—liver cancer	7.76e-05	0.00117	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GOT1—liver cancer	7.73e-05	0.00116	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GGT1—liver cancer	7.73e-05	0.00116	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—MTHFR—liver cancer	7.65e-05	0.00115	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPARA—liver cancer	7.5e-05	0.00113	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NR1H4—liver cancer	7.48e-05	0.00112	CbGpPWpGaD
Zoledronate—CA12—Metabolism—MTHFR—liver cancer	7.38e-05	0.00111	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTA3—liver cancer	7.35e-05	0.0011	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CG—liver cancer	7.35e-05	0.0011	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPARA—liver cancer	7.24e-05	0.00109	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ALDOB—liver cancer	7.16e-05	0.00108	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PPARG—liver cancer	7.1e-05	0.00107	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—HMOX1—liver cancer	7.08e-05	0.00106	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CA—liver cancer	7.03e-05	0.00106	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTP1—liver cancer	6.94e-05	0.00104	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HMOX1—liver cancer	6.85e-05	0.00103	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.74e-05	0.00101	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTA4—liver cancer	6.73e-05	0.00101	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	6.57e-05	0.000987	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTA2—liver cancer	6.56e-05	0.000984	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CD—liver cancer	6.46e-05	0.000971	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CG—liver cancer	6.43e-05	0.000965	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTM1—liver cancer	6.38e-05	0.000958	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ALB—liver cancer	6.38e-05	0.000958	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTA1—liver cancer	6.32e-05	0.00095	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NAT2—liver cancer	6.25e-05	0.000939	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPARG—liver cancer	6.2e-05	0.000931	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CG—liver cancer	6.2e-05	0.000931	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP1A1—liver cancer	6.05e-05	0.000908	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	6.01e-05	0.000903	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALDOB—liver cancer	6e-05	0.0009	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPARG—liver cancer	5.98e-05	0.000898	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—AKT1—liver cancer	5.74e-05	0.000863	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CRABP1—liver cancer	5.72e-05	0.000859	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—PPARA—liver cancer	5.72e-05	0.000859	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ADAM17—liver cancer	5.66e-05	0.00085	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CD—liver cancer	5.65e-05	0.000848	CbGpPWpGaD
Zoledronate—CA2—Metabolism—MTHFR—liver cancer	5.64e-05	0.000847	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CB—liver cancer	5.63e-05	0.000846	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ALB—liver cancer	5.58e-05	0.000837	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARA—liver cancer	5.53e-05	0.000831	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CD—liver cancer	5.45e-05	0.000818	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ALB—liver cancer	5.38e-05	0.000808	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PSMA4—liver cancer	5.32e-05	0.000799	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PSMD10—liver cancer	5.32e-05	0.000799	CbGpPWpGaD
Zoledronate—ABCC1—Disease—GOT2—liver cancer	5.18e-05	0.000777	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.15e-05	0.000773	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HPGDS—liver cancer	5e-05	0.000751	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.97e-05	0.000746	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CB—liver cancer	4.92e-05	0.000739	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CB—liver cancer	4.75e-05	0.000713	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CG—liver cancer	4.74e-05	0.000711	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARG—liver cancer	4.57e-05	0.000687	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.53e-05	0.00068	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.47e-05	0.000671	CbGpPWpGaD
Zoledronate—ABCC1—Disease—GOT1—liver cancer	4.47e-05	0.000671	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PSMD10—liver cancer	4.46e-05	0.000669	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PSMA4—liver cancer	4.46e-05	0.000669	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GOT2—liver cancer	4.33e-05	0.000651	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ALB—liver cancer	4.25e-05	0.000638	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CD—liver cancer	4.16e-05	0.000625	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PRKCE—liver cancer	4.12e-05	0.000619	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALB—liver cancer	4.11e-05	0.000617	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2E1—liver cancer	4.08e-05	0.000612	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.95e-05	0.000593	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—RAF1—liver cancer	3.84e-05	0.000577	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYCS—liver cancer	3.81e-05	0.000573	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GOT1—liver cancer	3.74e-05	0.000562	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GGT1—liver cancer	3.74e-05	0.000562	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CB—liver cancer	3.63e-05	0.000545	CbGpPWpGaD
Zoledronate—ABCC1—Disease—H2AFX—liver cancer	3.59e-05	0.00054	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CA—liver cancer	3.43e-05	0.000516	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTP1—liver cancer	3.36e-05	0.000505	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HMOX1—liver cancer	3.31e-05	0.000498	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTHFR—liver cancer	3.26e-05	0.000489	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TERT—liver cancer	3.25e-05	0.000488	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTM1—liver cancer	3.09e-05	0.000464	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CA—liver cancer	3e-05	0.000451	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP1A1—liver cancer	2.93e-05	0.00044	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CA—liver cancer	2.89e-05	0.000435	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AKT1—liver cancer	2.81e-05	0.000421	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APC—liver cancer	2.74e-05	0.000411	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTHFR—liver cancer	2.73e-05	0.00041	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARA—liver cancer	2.68e-05	0.000402	CbGpPWpGaD
Zoledronate—ABCC1—Disease—BRAF—liver cancer	2.57e-05	0.000387	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKT1—liver cancer	2.45e-05	0.000368	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CD—liver cancer	2.41e-05	0.000362	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.41e-05	0.000361	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SERPINE1—liver cancer	2.38e-05	0.000358	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AKT1—liver cancer	2.36e-05	0.000355	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CG—liver cancer	2.29e-05	0.000344	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARG—liver cancer	2.21e-05	0.000332	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CA—liver cancer	2.21e-05	0.000332	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RAF1—liver cancer	2.15e-05	0.000323	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CB—liver cancer	2.1e-05	0.000315	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTOR—liver cancer	2.1e-05	0.000315	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CD—liver cancer	2.02e-05	0.000303	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALB—liver cancer	1.99e-05	0.000299	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1B—liver cancer	1.97e-05	0.000296	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CTNNB1—liver cancer	1.86e-05	0.000279	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1A—liver cancer	1.82e-05	0.000273	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKT1—liver cancer	1.81e-05	0.000271	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CB—liver cancer	1.76e-05	0.000264	CbGpPWpGaD
Zoledronate—ABCC1—Disease—STAT3—liver cancer	1.62e-05	0.000244	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MYC—liver cancer	1.51e-05	0.000226	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TGFB1—liver cancer	1.5e-05	0.000226	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KRAS—liver cancer	1.39e-05	0.000209	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CA—liver cancer	1.28e-05	0.000192	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HRAS—liver cancer	1.18e-05	0.000178	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6—liver cancer	1.13e-05	0.00017	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CA—liver cancer	1.07e-05	0.000161	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT1—liver cancer	1.05e-05	0.000157	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKT1—liver cancer	8.75e-06	0.000131	CbGpPWpGaD
